Bioretec Oy
Research Bioretec Oy (BRETEC) on Bullrun: market cap EUR 28.71M, P/E 0.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBRETEC
- ExchangeHE
- CountryFinland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 28.71M
- P/E0.1
- Financial periodFY2025
- RevenueEUR 3.52M
- Revenue growth-22.5%
- Net income-EUR 9.48M
- Free cash flow-EUR 10.35M
- Gross margin65.7%
Valuation Snapshot
latest market cap is EUR 28.71M; P/E is 0.1.
Peer valuation comparison
Latest P/E is 0.11x versus a Healthcare sector median of 24.46x (99.5% below).
Latest P/E is 0.11x versus a Finland median of 18.47x (99.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 3.52M | -EUR 9.48M | -EUR 10.35M | 65.7% | n/a | EUR 1.08M | EUR 434.27K | EUR 9.76M |
| FY2024 | EUR 4.54M | -EUR 4.61M | -EUR 5.84M | 70.9% | -0.02 | EUR 3.84M | EUR 671.16K | EUR 9.74M |
| FY2023 | EUR 3.91M | -EUR 3.79M | -EUR 3.60M | 69.8% | -0.02 | EUR 3.78M | EUR 1.05M | EUR 8.23M |
| FY2022 | EUR 2.94M | -EUR 2.42M | -EUR 2.62M | 72.6% | -0.01 | EUR 207.34K | EUR 712.92K | EUR 1.92M |
| FY2021 | n/a | n/a | n/a | n/a | -0.04 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 28.71M | 0.1 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Bioretec Oy
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bioretec Oy's market cap?
Bioretec Oy's market capitalization is EUR 28.71M.
What is Bioretec Oy's P/E ratio?
Bioretec Oy's price-to-earnings (P/E) ratio is 0.1.
What does Bioretec Oy do?
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery.